Literature DB >> 28559217

In vitro and in vivo behavior of ground tadalafil hot-melt extrudates: How the carrier material can effectively assure rapid or controlled drug release.

Anna Krupa1, Oriane Cantin2, Beata Strach3, Elżbieta Wyska3, Zbisław Tabor4, Juergen Siepmann2, Andrzej Wróbel5, Renata Jachowicz6.   

Abstract

Different types of ground hot-melt extrudates loaded with 10, 20 or 30 % of the poorly water-soluble drug tadalafil were prepared and characterized in vitro and in vivo (in rats). Soluplus was used as an amorphous carrier material, whereas mannitol and lactitol were studied as crystalline matrix formers. The systems were characterized using X-ray powder diffraction, thermogravimetric analysis coupled with quadruple mass spectrometry, differential scanning calorimetry, X-ray computed microtomography, in vitro drug release measurements and monitoring of drug plasma levels upon oral administration to rats. The pure drug substance and physical mixtures of tadalafil with the carrier materials were used as references. Importantly, the bioavailability of this poorly water-soluble drug could be substantially increased with the proposed formulations, and the in vitro and in vivo release rates could be effectively adjusted by choosing the appropriate type of carrier material: Whereas mannitol-based ground hot-melt extrudates rapidly released the drug and led to an early rise in drug plasma concentrations, Soluplus-based systems released tadalafil more slowly, resulting in delayed plasma peaks. These behaviors could be explained by the rapid disintegration/dissolution of the porous mannitol-based formulations, whereas Soluplus significantly swelled and the dissolved drug had to diffuse through the polymeric network prior to release. Blending these formulations can be expected to allow providing elevated drug concentrations in vivo during prolonged periods of time upon one single administration with a rapid onset of drug action.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hot-melt extrusion; Mannitol; Poor solubility; Soluplus; Tadalafil

Mesh:

Substances:

Year:  2017        PMID: 28559217     DOI: 10.1016/j.ijpharm.2017.05.057

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  4 in total

Review 1.  An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part I.

Authors:  Venkata Raman Kallakunta; Sandeep Sarabu; Suresh Bandari; Roshan Tiwari; Hemlata Patil; Michael A Repka
Journal:  Expert Opin Drug Deliv       Date:  2019-05-03       Impact factor: 6.648

2.  Application of hydrophilic polymers for the preparation of tadalafil solid dispersions: micromeritics properties, release and erectile dysfunction studies in male rats.

Authors:  Mohammed Muqtader Ahmed; Md Khalid Anwer; Gamal A Soliman; Mohammed F Aldawsari; Abdul Aleem Mohammed; Sultan Alshehri; Mohammed M Ghoneim; Amer S Alali; Abdullah Alshetaili; Ahmed Alalaiwe; Sarah I Bukhari; Ameeduzzafar Zafar
Journal:  PeerJ       Date:  2022-05-26       Impact factor: 3.061

Review 3.  Melt extrusion with poorly soluble drugs - An integrated review.

Authors:  Michael A Repka; Suresh Bandari; Venkata Raman Kallakunta; Anh Q Vo; Haley McFall; Manjeet B Pimparade; Ajinkya M Bhagurkar
Journal:  Int J Pharm       Date:  2017-11-02       Impact factor: 5.875

4.  A novel drug-drug coamorphous system without molecular interactions: improve the physicochemical properties of tadalafil and repaglinide.

Authors:  Meiling Su; Yanming Xia; Yajing Shen; Weili Heng; Yuanfeng Wei; Linghe Zhang; Yuan Gao; Jianjun Zhang; Shuai Qian
Journal:  RSC Adv       Date:  2020-01-02       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.